| Not Yet Recruiting | A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as Fir NCT07502027 | Huazhong University of Science and Technology | Phase 4 |
| Not Yet Recruiting | QLS5132 Combination Therapy in Advanced Solid Tumors NCT07453394 | Qilu Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/ NCT07515625 | Fudan University | Phase 2 |
| Not Yet Recruiting | To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Meta NCT07364422 | Onconic Therapeutics Inc. | Phase 1 / Phase 2 |
| Enrolling By Invitation | Early Postoperative Intervention in Gastric Cancer Patients NCT07444099 | Qilu Hospital of Shandong University | N/A |
| Not Yet Recruiting | Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC) NCT07401199 | Qun Zhao | — |
| Not Yet Recruiting | Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer NCT07331454 | The First Affiliated Hospital with Nanjing Medical University | Phase 3 |
| Active Not Recruiting | Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management NCT07522320 | Unidade Local De Saúde Do Norte Alentejano | — |
| Recruiting | SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure NCT07311408 | Jingdong Zhang | Phase 2 |
| Not Yet Recruiting | The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagn NCT07332104 | Beijing Friendship Hospital | — |
| Recruiting | Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer NCT07366528 | Ruijin Hospital | Phase 3 |
| Recruiting | Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer NCT07313579 | Ukrainian Society of Clinical Oncology | — |
| Recruiting | Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. NCT07217704 | SOFIE | Phase 3 |
| Recruiting | Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastat NCT07315854 | Beijing Friendship Hospital | Phase 2 |
| Not Yet Recruiting | Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer NCT07166263 | Base Therapeutics (Shanghai) Co., Ltd. | EARLY_Phase 1 |
| Not Yet Recruiting | Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors NCT07172503 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | N/A |
| Active Not Recruiting | Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment NCT07180966 | Ruijin Hospital | — |
| Not Yet Recruiting | Feasibility and Safety of Laparoscopic Purse-string Suture Clamp and Multi-functional Seal Cap for Totally Lap NCT07117812 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Recruiting | The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer NCT07183150 | Tianjin Medical University Cancer Institute and Hospital | — |
| Not Yet Recruiting | Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastri NCT07045805 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Recruiting | Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and NCT07165847 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 2 |
| Enrolling By Invitation | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Mali NCT07023861 | Affiliated Hospital of Jiangnan University | EARLY_Phase 1 |
| Enrolling By Invitation | Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gast NCT07176455 | Nanjing Medical University | — |
| Enrolling By Invitation | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors NCT07023848 | Affiliated Hospital of Jiangnan University | EARLY_Phase 1 |
| Recruiting | A Study of SH009 Injection in Patients With Advanced Solid Tumors. NCT07390838 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 |
| Enrolling By Invitation | Laparoscopic Staging for Stage III Gastric Cancer NCT07533825 | Tianjin Medical University Cancer Institute and Hospital | N/A |
| Recruiting | Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric NCT07441785 | P. Herzen Moscow Oncology Research Institute | — |
| Completed | Prehabilitation Plus ERAS in Gastric Cancer Surgery NCT07328633 | The Affiliated Hospital of Qingdao University | N/A |
| Recruiting | A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer NCT07224750 | City of Hope Medical Center | — |
| Active Not Recruiting | A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastroint NCT07104877 | Fujian Cancer Hospital | N/A |
| Completed | Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers NCT07184047 | Ankara Etlik City Hospital | — |
| Recruiting | PPG vs. ICG in Gastrointestinal Resections NCT06222645 | Saint Petersburg State University, Russia | N/A |
| Completed | Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-H NCT07177560 | Gazi University | — |
| Enrolling By Invitation | Prolonged Extubation in Gastric Cancer With OSA NCT07362706 | Qilu Hospital of Shandong University | — |
| Unknown | Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor NCT05009966 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Active Not Recruiting | Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer NCT07403916 | P. Herzen Moscow Oncology Research Institute | — |
| Completed | Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy NCT07190040 | Chang-Ming Huang, Prof. | — |
| Active Not Recruiting | Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylen NCT07147452 | Hospital del SAS de Jerez | — |
| Completed | Recurrence and Prognosis Prediction Model for Gastric Cancer NCT07243847 | Fudan University | — |